Minimal sex-differential modulation of reactivity to pathogens and toll-like receptor ligands following infant Bacillus Calmette–Guérin Russia vaccination
Bacillus Calmette–Guérin (BCG), the only licensed vaccine against tuberculosis, has been shown to provide heterologous protection against unrelated pathogens and enhance antibody responses to several routine expanded program on immunization (EPI) vaccines. Understanding these heterologous effects is...
主要な著者: | Darboe, F, Adetifa, JU, Reynolds, J, Hossin, S, Plebanski, M, Netea, MG, Rowland-Jones, SL, Sutherland, JS, Flanagan, KL |
---|---|
フォーマット: | Journal article |
出版事項: |
Frontiers Media
2017
|
類似資料
-
Minimal Sex-Differential Modulation of Reactivity to Pathogens and Toll-Like Receptor Ligands following Infant Bacillus Calmette–Guérin Russia Vaccination
著者:: Fatoumatta Darboe, 等
出版事項: (2017-09-01) -
Reiter's syndrome postintravesical Bacillus Calmette–Guérin instillations
著者:: Ng, K.L., 等
出版事項: (2017) -
Bacillus Calmette–Guérin Immunotherapy for Cancer
著者:: Fabíola Cardillo, 等
出版事項: (2021-05-01) -
Bacillus Calmette–Guérin and Bladder Cancer
著者:: Azad H.A. Razack
出版事項: (2007-10-01) -
Hepatitis in Disseminated Bacillus Calmette-Guérin Infection
著者:: Markus U Göttke, 等
出版事項: (2000-01-01)